IS7548A - Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur - Google Patents

Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur

Info

Publication number: IS7548A
Authority: IS; Iceland
Prior art keywords: epithelial; methods; protecting; cells during; during chemotherapy
Prior art date: 2002-05-31

Application number

IS7548A

Other languages

English (en)

Inventor

Eissner Guenther

Holler Ernst

Original Assignee

Klinikum Der Universitaet Regensburg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-31

Filing date

2004-11-24

Publication date

2004-11-24

2004-11-24 Application filed by Klinikum Der Universitaet Regensburg filed Critical Klinikum Der Universitaet Regensburg

2004-11-24 Publication of IS7548A publication Critical patent/IS7548A/is

Links

238000002512 chemotherapy Methods 0.000 title 1
210000002919 epithelial cell Anatomy 0.000 title 1
238000000034 method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Transplantation (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)

IS7548A 2002-05-31 2004-11-24 Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur IS7548A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38411402P	2002-05-31	2002-05-31
US38743802P	2002-06-11	2002-06-11
PCT/EP2003/005753 WO2003101468A1 (en)	2002-05-31	2003-06-02	Method for the protection of endothelial and epithelial cells during chemotherapy

Publications (1)

Publication Number	Publication Date
IS7548A true IS7548A (is)	2004-11-24

Family

ID=29715309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7548A IS7548A (is)	2002-05-31	2004-11-24	Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur

Country Status (16)

Country	Link
EP (1)	EP1509235A1 (is)
JP (1)	JP2005527636A (is)
CN (1)	CN1304011C (is)
AU (1)	AU2003238189A1 (is)
CA (1)	CA2487171A1 (is)
EA (1)	EA008213B1 (is)
HR (1)	HRP20041213A2 (is)
IL (1)	IL165353A0 (is)
IS (1)	IS7548A (is)
MX (1)	MXPA04011941A (is)
NO (1)	NO20045655L (is)
NZ (1)	NZ536864A (is)
PL (1)	PL374402A1 (is)
RS (1)	RS102504A (is)
UA (1)	UA83628C2 (is)
WO (1)	WO2003101468A1 (is)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20031714A1 (it)	2003-09-05	2005-03-06	Gentium Spa	Formazioni ad azione antitumorale.
EP2637672B1 (en) *	2010-11-12	2018-08-22	Gentium S.r.l.	Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
ES2660969T5 (es)	2012-06-22	2021-09-03	Gentium S R L	Método basado en euglobulina para determinar la actividad biológica de defibrotida
EP3026122A1 (en)	2014-11-27	2016-06-01	Gentium S.p.A.	Cellular-based method for determining the potency of defibrotide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU754242B2 (en) *	1997-04-28	2002-11-07	Arsinur Burcoglu	Method of treating HIV infection and related secondary infections thereof

2003
- 2003-06-02 CA CA002487171A patent/CA2487171A1/en not_active Abandoned
- 2003-06-02 JP JP2004508823A patent/JP2005527636A/ja active Pending
- 2003-06-02 CN CNB038125013A patent/CN1304011C/zh not_active Expired - Fee Related
- 2003-06-02 UA UA20041109654A patent/UA83628C2/ru unknown
- 2003-06-02 RS YU102504A patent/RS102504A/sr unknown
- 2003-06-02 HR HR20041213A patent/HRP20041213A2/xx not_active Application Discontinuation
- 2003-06-02 EP EP03735516A patent/EP1509235A1/en not_active Ceased
- 2003-06-02 MX MXPA04011941A patent/MXPA04011941A/es unknown
- 2003-06-02 EA EA200401448A patent/EA008213B1/ru not_active IP Right Cessation
- 2003-06-02 AU AU2003238189A patent/AU2003238189A1/en not_active Abandoned
- 2003-06-02 NZ NZ536864A patent/NZ536864A/en unknown
- 2003-06-02 WO PCT/EP2003/005753 patent/WO2003101468A1/en not_active Ceased
- 2003-06-02 PL PL03374402A patent/PL374402A1/xx not_active Application Discontinuation
2004
- 2004-11-23 IL IL16535304A patent/IL165353A0/xx unknown
- 2004-11-24 IS IS7548A patent/IS7548A/is unknown
- 2004-12-27 NO NO20045655A patent/NO20045655L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MXPA04011941A (es)	2005-07-26
CN1655801A (zh)	2005-08-17
NO20045655L (no)	2004-12-27
PL374402A1 (en)	2005-10-17
NZ536864A (en)	2008-08-29
WO2003101468A1 (en)	2003-12-11
JP2005527636A (ja)	2005-09-15
EA200401448A1 (ru)	2005-06-30
IL165353A0 (en)	2006-01-15
AU2003238189A1 (en)	2003-12-19
HRP20041213A2 (hr)	2006-04-30
EP1509235A1 (en)	2005-03-02
UA83628C2 (ru)	2008-08-11
CN1304011C (zh)	2007-03-14
CA2487171A1 (en)	2003-12-11
RS102504A (sr)	2006-12-15
EA008213B1 (ru)	2007-04-27

Publication	Publication Date	Title
EP1537585A4 (en)	2007-08-15	Memory cell
DE60330151D1 (de)	2009-12-31	Brennstoffzellensystem
DE10324396A8 (de)	2005-05-04	Brennstoffzelle
DE60316596D1 (de)	2007-11-08	Brennstoffzellensystem
DE60326112D1 (de)	2009-03-26	Brennstoffzellensystem
NO20031285L (no)	2003-09-22	Isolasjons-omlöps-overgangsskjöt
DE60331474D1 (de)	2010-04-08	Brennstoffzellensystem
DE602004026708D1 (de)	2010-06-02	Brennstoffzellensystem
NO20032504L (no)	2003-12-05	Tetningsblanding
DE60331959D1 (de)	2010-05-12	Brennstoffzellensystem
DE60329024D1 (de)	2009-10-08	Brennstoffzelle
DE60207518D1 (de)	2005-12-29	Dämpfungseinrichtung
DE50303161D1 (de)	2006-06-08	Zentrierspanner
DE60303345D1 (de)	2006-04-13	Brennstoffzelle
IS7826A (is)	2005-04-27	Lekaskorða fyrir raflausnarker
DE60321289D1 (de)	2008-07-10	Brennstoffzellensystem
DE60323022D1 (de)	2008-10-02	Brennstoffzelle
DE60312367D1 (de)	2007-04-19	Brennstoffzellensystem
DE502004008433D1 (de)	2008-12-18	Wägezelle
IS7548A (is)	2004-11-24	Aðfer til þess að vernda innþekju- og útþekjufrumur meðan á efnameðferð stendur
DK1768691T3 (da)	2013-07-01	Aequorinholdige præparater og fremgangsmåder til anvendelse af samme
DE60314807D1 (de)	2007-08-23	Dichtungsvorrichtung
DE60329145D1 (de)	2009-10-22	Dichtungsvorrichtung
FR2834557B1 (fr)	2004-04-02	Station spatiale oceanique
EP1515386A4 (en)	2009-12-30	COMBUSTIBLE CELL